View More Recent Stories

Feb 3, 2025 06:32AM AxoGen, Inc. (AXGN) PT Raised to $22 at Canaccord Genuity

Jan 10, 2025 08:02AM AxoGen (AXGN) Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024

Nov 7, 2024 08:29AM AxoGen (AXGN) Tops Q3 EPS by 6c

Sep 6, 2024 07:00AM AxoGen (AXGN) Completes Submission of BLA to U.S. Food and Drug Administration for Avance Nerve Graft®

Aug 8, 2024 07:19AM AxoGen (AXGN) Tops Q2 EPS by 11c, provides guidance

Aug 8, 2024 07:05AM AxoGen (AXGN) Appoints Michael Dale as CEO

View More Recent Stories